Significant progress for hereditary angioedema condition

Imaging agent to improve prostate cancer detection

Potential treatment for multiple system atrophy shows promise

UCB’s BIMZELX reveals promising two-year data at EHSF 2025

New immunotherapy offers hope for recurrent cervical cancer

Treatment expands options for HER2-negative metastatic breast cancer

New methodology may boost innovation in protein engineering

CSL Behring’s study reveals significant long-term benefits

Partnership aims to leverage cutting-edge technology in clinical trials

Designation follows promising preclinical data and FDA clearance